Why Surgery Partners (SGRY) stock rose 14.0% on Nov 9, 2026
Surgery Partners rose 14.0%. Benzinga reported: “UnitedHealth Is Said To Have Bid $28 Per Share For Surgery Partners” (7:00 am ET). Surgery Partners also filed an 8-K reporting a material agreement with the SEC. SPY rose 2.4% and its sector ETF, XLV, rose 1.9%.
The move
SGRY gapped up 11.2% at the open and closed up 14.0%.
| Reading (ET) | Change | SPY | Sector ETF |
|---|---|---|---|
| Open · 9:30 am | +11.2% | +0.9% | XLV +0.9% |
| Close · 4:00 pm | +14.0% | +2.4% | XLV +1.9% |
Sources
- Benzinga, 7:00 am ET: “UnitedHealth Is Said To Have Bid $28 Per Share For Surgery Partners”
- 8-K (Items 1.01, 7.01, 9.01): filed with the SEC.
Valuation before and after
In the weekly snapshot of Nov 7, 2026, SGRY had a Blended P/E of 63.8 against a Normal P/E of 33.6. As of Nov 18, 2026, its Blended P/E is 74.1 against a Normal P/E of 33.6.
Context
Earlier moves in SGRY
This is the first move we have recorded for SGRY.
What happened next
- After 5 sessions (Nov 16, 2026): SGRY +1.3% from its close on Nov 9, 2026, SPY -1.7%.
- We add the 20-session move on Dec 9, 2026.
Corrections
- Nov 14, 2026: Link changed from the news feed's redirect to the article's own address.
The question
Why did Surgery Partners (SGRY) stock rise 14.0% on Nov 9, 2026?
Surgery Partners rose 14.0%. Benzinga reported: “UnitedHealth Is Said To Have Bid $28 Per Share For Surgery Partners” (7:00 am ET). Surgery Partners also filed an 8-K reporting a material agreement with the SEC. SPY rose 2.4% and its sector ETF, XLV, rose 1.9%.